Recent advances in the understanding of interleukin-2 signal transduction

Journal of Clinical Immunology

Volumn 18, Issue 5, 1998, Pages 307-320

  Gesbert, Franck ^a   Delespine Carmagnat, Maryvonnick ^a   Bertoglio, Jacques ^a  

^a INSERM   (France)

Author keywords

Interleukin 2; Signal transduction

Indexed keywords

ADAPTOR PROTEIN; COMPLEMENTARY DNA; CYTOKINE; CYTOKINE RECEPTOR; FAS ANTIGEN; FAS LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TYROSINE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME SUBSTRATE; GENETIC TRANSCRIPTION; HUMAN; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; INTERLEUKIN-2; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION;

EID: 0031694552     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023223614407     Document Type: Article

References (123)

1. Morgan DA, Ruscetti FW, Gullo R: Selective in vitro growth of T lymphocytes from normal human hone marrows. Science 193:1007-1008, 1976
2. Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R, Hamuro J: Structure and expression of a cloned cDNA for human interleukin-2. Nature 302:305-310, 1983
3. Lenardo MJ: Fas and the art of lymphocyte maintenance. J Exp Med 183:721-724, 1996
4. Piazza C, Gilardini Montani MS, Moretti S, Cundari E, Piccolella E: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis. J Immunol 158:1503-1506, 1997
5. Smith KA: Interleukin-2: inception, impact, and implications. Science 240:1169-1176, 1988
6. Bazan JF: Haemopoietic receptors and helical cytokines. Immunol Today 11:350-354, 1990
7. Theze J: Cytokine receptors: a combinative family of molecules. Eur Cytokine Netw 5:353-368, 1994
8. Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T: Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA 88:11349-11353, 1991
9. Goldsmith MA, Xu W, Amaral MC, Kuczek ES, Greene WC: The cytoplasmic domain of the interleukin-2 receptor β chain contains both unique and functionally redundant signal transduction elements. J Biol Chem 269:14698-14704, 1994
10. Goldsmith MA, Lai SY, Xu W, Amaral MC, Kuczek ES, Parent LJ, Mills GB, Tarr KL, Longmore GD, Greene WC: Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the β chain and non-tyrosine residues of the γ c chain. J Biol Chem 270:21729-21737, 1995
11. Miyazaki T, Liu ZJ, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Permutter RM, Taniguchi T: Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81:223-231, 1995
12. Saltzman EM, Thom RR, Casnellie JE: Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2. J Biol Chem 263:6956-6959, 1988
13. Nakamura Y, Russell SM, Mess SA, Friedmann M, Erdos M, Francois C, Jacques Y, Adelstein S, Leonard WJ: Heterodimerization of the IL-2 receptor β-and γ-chain cytoplasmic domains is required for signalling. Nature 369:330-333, 1994
14. Nelson BH, Lord JD Greenberg PD: Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature 369:333-336, 1994
15. Hatakeyama M, Kono T, Kobayashi N, Kawahara A, Levin SD, Perlmutter RM, Taniguchi T: Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science 252:1523-1528, 1991
16. Minami Y, Kono T, Yamada K, Kobayashi N, Kawahara A, Perlmutter RM, Taniguchi T: Association of p56lck with IL-2 receptor β chain is critical for the IL-2-induced activation of p56lck. EMBO J 12:759-768, 1993
17. Kobayashi N Kono T, Hatakeyama M, Minami Y, Miyazaki T, Perlmutter RM, Taniguchi T: Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: Implications for redundancy and pleiotropism in cytokine signal transduction. Proc Natl Acad Sci USA 90:4201-4205, 1993
18. Minami Y, Nakagawa Y, Kawahara A, Miyazaki T, Sada K, Yamamura H, Taniguchi T: Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity 2:89-100, 1995
19. Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu ZJ, Oishi I, Silvennoinen O, Witthuhn BA, Ihle JN, et al.: Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045-1047, 1994
20. Velazquez, L, Fellous M, Stark GR, Pellegrini S: A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70:313-322, 1992
21. Muller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, Harpur AG, Barbieri G, Witthuhn BA, Schindler C, et al.: The protein tyrosine kinase JAK1 complements defects in interferon-α/ß and -γ signal transduction. Nature 366:129-135, 1993
22. Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA: Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci USA 93:9148-9153, 1996
23. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM: Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379:645-648, 1996
24. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone TS, Noguchi M, Markert ML, Buckley RH, et al.: Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797-800, 1995
25. Kawahara A, Minami Y, Miyazaki T, Ihle JN, Taniguchi T: Critical role of the interleukin 2 (IL-2) receptor γ-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc Natl Acad Sci USA 92:8724-8728, 1995
26. Nosaka T, van Deursen JM, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN: Defective lymphoid development in mice lacking Jak3. Science 270:800-802, 1995
27. Zhao Y, Wagner F, Frank SJ, Kraft AS: The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor β c chain. J Biol Chem 270:13814-13818, 1995
28. Chen M, Cheng A, Chen YQ, Hymel A, Hanson EP, Kimmel L, Minami Y, Taniguchi T, Changelian PS, JJ OS: The amino terminus of JAK3 is necessary and sufficient for binding to the common y chain and confers the ability to transmit interleukin 2-mediated signals. Proc Natl Acad Sci USA 94:6910-6915, 1997
29. Higuchi M, Asao H, Tanaka N, Oda K, Takeshita T, Nakamura M, Van Snick J, Sugamura K: Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line. Eur J Immunol 26:1322-1327, 1996
30. Molina TJ, Kishihara K, Siderovski DP, van Ewijk W, Narendran A, Timms E, Wakeham A, Paige CJ, Hartmann KU, Veillette A, et al.: Profound block in thymocyte development in mice lacking p56lck. Nature 357:161-164, 1992
31. Horak ID, Gress RE, Lucas PJ, Horak EM, Waldmann TA, Bolen JB: T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck. Proc Natl Acad Sci USA 88:1996-2000, 1991
32. Ellis C, Moran M, McCormick F, Pawson T: Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 343:377-381, 1990
33. Amrein KE, Flint N, Panholzer B, Burn P: Ras GTPase-activating protein: A substrate and a potential binding protein of the protein-tyrosine kinase p56lck. Proc Natl Acad Sci USA 89: 3343-3346, 1992
34. Vogel LB, Fujita DJ: p70 phosphorylation and binding to p56lck is an early event in interleukin-2-induced onset of cell cycle progression in T-lymphocytes. J Biol Chem 270:2506-2511, 1995
35. Karnitz L, Sutor SL, Torigoe T, Reed JC, Bell MP, McKean DJ, Leibson PJ, Abraham RT: Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line. Mol Cell Biol 12:4521-4530, 1992
36. Mills GB, Arima N, May C, Hill M, Schmandt R, Li J, Miyamoto NG, Greene WC: Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells. Int Immunol 4:1233-1243, 1992
37. Weiss A, Littman DR: Signal transduction by lymphocyte antigen receptors. Cell 76:263-274, 1994
38. Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A: Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 5:591-604, 1996
39. Evans GA, Howard OM, Erwin R, Farrar WL: Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: Lack of requirement for the tyrosine kinase lck. Biochem J 294:339-342, 1993
40. Asao H, Takeshita T, Nakamura M, Nagata K, Sugamura K: Interleukin 2 (IL-2)-induced tyrosine phosphorylation of IL-2 receptor p75. J Exp Med 171:637-644, 1990
41. Asao H, Kumaki S, Takeshita T, Nakamura M, Sugamura K: IL-2-dependent in vivo and in vitro tyrosine phosphorylation of IL-2 receptor y chain. FEBS Lett 304:141-145, 1992
42. Friedmann MC, Migone TS, Russell SM, Leonard WJ: Different interleukin 2 receptor β-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci USA 93:2077-2082, 1996
43. Oakes SA, Candotti F, Johnston JA, Chen YQ, Ryan JJ, Taylor N, Liu X, Hennighausen L, Notarangelo LD, Paul WE, Blaese RM, O'Shea JJ: Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 5:605-615, 1996
44. Gaffen SL, Lai SY, Ha M, Liu X, Hennighausen L, Greene WC, Goldsmith MA: Distinct tyrosine residues within the interleukin-2 receptor β chain drive signal transduction specificity, redundancy, and diversity. J Biol Chem 271:21381-21390, 1996
45. Fujii H, Nakagawa Y, Schindler U, Kawahara A, Mori H, Gouilleux F, Groner B, Ihle JN, Minami Y, Miyazaki T, et al.: Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal transmission. Proc Natl Acad Sci USA 92:5482-5486, 1995
46. Darnell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421, 1994
47. Gilmour KC, Pine R, Reich NC: Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci USA 92:10772-10776, 1995
48. Frank DA, Robertson MJ, Bonni A, Ritz J, Greenberg ME: Interleukin 2 signaling involves the phosphorylation of Stat proteins. Proc Natl Acad Sci USA 92:7779-7783, 1995
49. Nielsen M, Svejgaard A, Skov S, Odum N: Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Bur J Immunol 24:3082-3086, 1994
50. Beadling C, Ng J, Babbage JW, Cantrell DA: Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J 15:1902-1913, 1996
51. Wen Z, Zhong Z, Darnell JE Jr: Maximal activation of transcription by Stat1 and Stat3 requires both lyrosine and serine phosphorylation. Cell 82:241-250, 1995
52. Kirken RA, Malabarba MG, Xu J, DaSilva L, Erwin RA, Liu X, Hennighausen L, Rui H, Farrar WL: Two discrete regions of interleukin-2 (IL2) receptor β independently mediate IL2 activation of a PD98059/rapamycin/wortmannin-insensitive Stat5a/b serine kinase. J Biol Chem 272:15459-15465, 1997
53. Wang D, Stravopodis D, Teglund S, Kitazawa J, Ihle JN: Naturally occurring dominant negative variants of Stat5. Mol Cell Biol 16:6141-6148, 1996
54. Nakajima H, Liu XW, Wynshaw-Boris A, Rosenthal LA, Imada K, Finbloom DS, Hennighausen L, Leonard WJ: An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity 7:691-701, 1997
55. John S, Robbins CM, Leonard WJ: An IL-2 response element in the human IL-2 receptor α chain promoter is a composite element that hinds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J 15:5627-5635, 1996
56. Lecine P, Algarte M, Rameil P, Beadling C, Bucher P, Nabholz, M, Imbert J: Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor α gene. Mol Cell Biol 16:6829-6840, 1996
57. Mui AL, Wakao H, Kinoshita T, Kitamura T, Miyajima A: Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of Stat5 in proliferation. EMBO J 15:2425-2433, 1996
58. Dautry F, Weil D, Yu J, Dautry-Varsat A: Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines. J Biol Chem 263:17615-17620, 1988
59. Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T, Miyajima A: A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J 14:2816-2826, 1995
60. Feldman GM, Rosenthal LA, Liu X, Hayes MP, Wynshaw-Boris A, Leonard WJ, Hennighausen L, Finbloom DS: STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90:1768-1776, 1997
61. Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, Yoshimura A: CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89:3148-3154, 1997
62. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyuzaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924, 1997
63. Aman MJ, Leonard WJ: Cytokine-inducible signaling inhibitors. Curr Biol 7:784-788, 1997
64. Bos JL: ras oncogenes in human cancer: A review. Cancer Res 49:4682-4689, 1989
65. Sakai N, Ogiso Y, Fujita H, Watari H, Koike T, Kuzumaki N: Induction of apoptosis by a dominant negative H-RAS mutant (116Y) in K562 cells. Exp Cell Res 215:131-136, 1994
66. Kinoshita T, Yokota T, Arai K, Miyajima A: Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene 10:2207-2212, 1995
67. Chen CY, Faller DV: Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene 11:1487-1498, 1995
68. Graves JD, Downward J, Izquierdo-Pastor M, Rayter S, Warne PH, Cantrell DA: The growth factor IL-2 activates p21ras proteins in normal human T lymphocytes. J Immunol 148:2417-2422, 1992
69. Satoh T, Nakafuku M, Kaziro Y: Function of Ras as a molecular switch in signal transduction. J Biol Chem 267:24149-24152, 1992
70. Zhu X, Suen KL, Barbacid M, Bolen JB, Fargnoli J: Interleukin-2-induced tyrosine phosphorylation of She proteins correlates with factor-dependent T cell proliferation. J Biol Chem 269: 5518-5522, 1994
71. Ravichandran KS, Burakoff SJ: The adapter protein She interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J Biol Chem 269:1599-1602, 1994
72. Evans GA, Goldsmith MA, Johnston JA, Xu W, Weiler SR, Erwin R, Howard OM, Abraham RT, JJ OS, Greene WC, et al.: Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require She phosphorylation or receptor association. J Biol Chem 270:28858-28863, 1995
73. Satoh T, Minami Y, Kono T, Yamada K, Kawahara A, Taniguchi T, Kaziro Y: Interleukin 2-induced activation of Ras requires two domains of interleukin 2 receptor β subunit, the essential region for growth stimulation and Lck-hinding domain. J Biol Chem 267:25423-25427, 1992
74. Perkins GR, Marvel J, Collins MK: Interleukin 2 activates extracellular signal-regulated protein kinase 2. J Exp Med 178: 1429-1434, 1993
75. de Vries-Smits AM, Burgering BM, Leevers SJ, Marshall CJ, Bos JL: Involvement of p21ras in activation of extracellular signal-regulated kinase 2. Nature 357:602-604, 1992
76. Crawley JB, Rawlinson L, Lali FV, Page TH, Saklatvala J, Foxwell BM: T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J Biol Chem 272:15023-15027, 1997
77. Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M: Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354:494-196, 1991
78. Binetruy B, Smeal T, Karin M: Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351:122-127, 1991
79. Kapeller R, Cantley LC: Phosphatidylinositol 3-kinase. Bioessays 16:565-576, 1994
80. Inukai K, Funaki M, Ogihara T, Katagiri H, Kanda A, Anai M, Fukushima Y, Hosaka T, Suzuki M, Shin BC, Takata K, Yazaki Y, Kikuchi M, Oka Y, Asano T: p85a gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (Pi 3-kinase), p50α, p55α, and p85α, with different Pi 3-kinase activity elevating responses to insulin. J Biol Chem 272:7873-7882, 1997
81. Antonetti DA, Algenstaedt P, Kahn CR: Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol Cell Biol 16:2195-2203, 1996
82. Pons S, Asano T, Glasheen E, Miralpeix M, Zhang Y, Fisher TL, Myers MG Jr, Sun XJ, White MF: The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Mol Cell Biol 15:4453-4465, 1995
83. Gout I, Dhand R, Panayotou G, Fry MJ, Hiles I, Otsu M, Waterfield MD: Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 β protein by using the baculovirus expression system. Biochem J 288:395-405, 1992
84. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, et al.: SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778, 1993
85. Augustine JA, Sutor SL, Abraham RT: Interleukin 2-and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes. Mol Cell Biol 11:4431-4440, 1991
86. Merida I, Diez E, Gaulton GN: IL-2 binding activates a tyrosine-phosphorylated phosphatidylinositol-3-kinase. J Immunol 147: 2202-2207, 1991
87. Reif K, Nobes CD, Thomas G, Hall A, Cantrell DA: Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/ Rho-dependent effector pathways. Curr Biol 6:1445-1455, 1996
88. Vogel LB, Fujita DJ: The SH3 domain of p56lck is involved in binding to phosphatidylinositol 3′-kinase from T lymphocytes. Mol Cell Biol 13:7408-7417, 1993
89. Taichman R, Merida I, Torigoe T, Gaulton GN, Reed JC: Evidence that protein tyrosine kinase p56-Lck regulates the activity of phosphatidylinositol-3′-kinase in interleukin-2-dependent T-cells. J Biol Chem 268:20031-20036, 1993
90. Kanazawa T, Keeler ML, Varticovski L: Serine-rich region of the IL-2 receptor β-chain is required for activation of phosphatidylinositol 3-kinase. Cell Immunol 156:378-388, 1994
91. Truitt KE, Mills GB, Turck CW, Imboden JB: SH2-dependent association of phosphatidylinositol 3′-kinase 85-kDa regulatory subunit with the interleukin-2 receptor βchain. J Biol Chem 269:5937-5943, 1994
92. Monfar M, Lemon KP, Grammer TC, Cheatham L, Chung J, Vlahos CJ, Blenis J: Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinosilol 3-kinase and inhibited by cyclic AMP. Mol Cell Biol 15:326-337, 1995
93. Reif K, Burgering BM, Cantrell DA: Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J Biol Chem 272:14426-14433, 1997
94. Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN: Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA 94:3627-3632, 1997
95. Gonzalez-Garcia A, Merida I, Martinez AC, Carrera AC: Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 272:10220-10226, 1997
96. Gomez J, Martinez C, Garcia A, Rebollo A: Association of phosphatidylinositol 3 kinase to protein kinase C zeta during interleukin-2 stimulation. Eur J Immunol 26:1781-1787, 1996
97. Gomez J, Garcia A, L R-B, Bonay P, Martinez AC, Silva A, Fresno M, Carrera AC, Eicher-Streiber C, Rebollo A: IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-zeta. J Immunol 158:1516-1522, 1997
98. Neel BG: Role of phosphatases in lymphocyte activation. Curr Opin Immunol 9:405-420, 1997
99. Frearson JA, Alexander DR: The role of phosphotyrosine phosphatases in haematopoietic cell signal transduction. Bioessays 19:417-427, 1997
100. Pingel JT, Thomas ML: Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 58:1055-1065, 1989
101. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR: Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445-1454, 1993
102. Milarski KL, Saltiel AR: Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J Biol Chem 269:21239-21243, 1994
103. Bennett AM, Hausdorff SF, AM OR, Freeman RM, Neel BG: Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol Cell Biol 16:1189-1202, 1996
104. Adachi M, Ishino M, Torigoe T, Minami Y, Matozaki T, Miyazaki T, Taniguchi T, Hinoda Y, Imai K: Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor β chain. Oncogene 14:1629-1633, 1997
105. Nelson BH, McIntosh BC, Rosencrans LL, Greenberg PD: Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor γ(c) chain for Janus kinase activation leading to T cell proliferation. Proc Natl Acad Sci USA 94:1878-1883, 1997
106. Tauchi T, Feng GS, Shen R, Hoatlin M, Bagby GC Jr, Kabat D, Lu L, Broxmeyer HE: Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Chem 270:5631-5635, 1995
107. Adachi M, Torigoe T, Sekiya M, Minami Y, Taniguchi T, Hinoda Y, Yachi A, Reed JC, Imai K: IL-2-induced gene expression of protein-tyrosine phosphatase LC-PTP requires acidic and serine-rich regions within IL-2 receptor β chain. FEBS Lett 372:113-118, 1995
108. Takeshita T, Arita T, Higuchi M, Asao H, Endo K, Kuroda H, Tanaka N, Murata K, Ishii N, Sugamura K: STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity 6:449-457, 1997
109. Gesbert F, Garbay C, Bertoglio J: Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells. J Biol Chem 273:3986-3993, 1998
110. Langdon WY, Hartley JW, Klinken SP, Ruscetti SK, Morse HCd: v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc Natl Acad Sci USA 86:1168-1172, 1989
111. Blake TJ, Shapiro M, Morse HCd, Langdon WY: The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653-657, 1991
112. Mayer BJ, Hamaguchi M, Hanafusa H: A novel viral oncogene with structural similarity to phospholipase C. Nature 332:272-275, 1988
113. Matsuda M, Tanaka S, Nagata S, Kojima A, Kurata T, Shibuya M: Two species of human CRK cDNA encode proteins with distinct biological activities. Mol Cell Biol 12:3482-3489, 1992
114. ten Hoeve J, Morris C, Heisterkamp N, Groffen J: Isolation and chromosomal localization of CRKL. a human crk-like gene. Oncogene 8:2469-2474, 1993
115. ten Hoeve J, Kaartinen V, Fioretos T, Haataja L, Voncken JW, Heisterkamp N, Groffen J: Cellular interactions of CRKL, and SH2-SH3 adaptor protein. Cancer Res 54:2563-2567, 1994
116. Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV, Griffin JD: Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit. phosphatidylinositol 3-kinase, and p120(CBL). J Biol Chem 272:10248-10253, 1997
117. Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ, Band H: Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J Biol Chem 271: 8435-8442, 1996
118. Sattler M, Salgia R, Shrikhande G, Verma S, Uemura N, Law SF, Golemis EA, Griffin JD: Differential signaling after β1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1). J Biol Chem 272:14320-14326, 1997
119. Ota Y, Samelson LE: The product of the proto-oncogene c-cbl: A negative regulator of the Syk tyrosine kinase. Science 276:418-420, 1997
120. Frech M, John J, Pizon V, Chardin P, Tavitian A, Clark R, McCormick F, Wittinghofer A: Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. Science 249:169-171, 1990
121. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147-157, 1993
122. Sharfe N, Dadi HK, Shahar M, Roifman CM: Human immune disorder arising from mutation of the a chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 94:3168-3171, 1997
123. Brennan P, Babbage JW, Burgering BM, Groner B, Reif K, Cantrell DA: Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7:679-689, 1997